Cargando…
Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination
BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), began in late 2019. One of the vaccines approved against COVID-19 is the BNT162b2 mRNA COVID-19 vaccine (Pfizer/BioNTech). CASE PRESENTATION: We present the case of a...
Autores principales: | Nishiguchi, Yamato, Matsuyama, Hirofumi, Maeda, Kuniko, Shindo, Akihiro, Tomimoto, Hidekazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598937/ https://www.ncbi.nlm.nih.gov/pubmed/34789193 http://dx.doi.org/10.1186/s12883-021-02489-x |
Ejemplares similares
-
Cerebral Embolism Associated with Calcified Amorphous Tumor: A Review of Cerebral Infarction Cases
por: Nishiguchi, Yamato, et al.
Publicado: (2021) -
Pediatric Miller Fisher Syndrome; Characteristic Presentation and Comparison with Adult Miller Fisher Syndrome
por: Jang, Yeonji, et al.
Publicado: (2020) -
Recurrent Miller Fisher Syndrome
por: Ooi, Say Ting, et al.
Publicado: (2022) -
Clinical Features of Miller-Fisher Syndrome in Pregnancy
por: Ono, Masanori, et al.
Publicado: (2015) -
Miller Fisher syndrome with sinus arrest
por: Shiraiwa, Nobuko, et al.
Publicado: (2017)